Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Urtica dioica extract may help treat androgenic skin diseases by reducing a specific gene's activity.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Prostate cancer screening doesn't significantly reduce death rates and has risks like overdiagnosis and side effects.

Urinary PSA could be an early marker for enlarged prostate.

Biofeedback treatment for dysfunctional voiding in adults showed no symptom improvement.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

CAG repeat polymorphism and prostate zone volume are not reliable markers of long-term androgen sensitivity.

Low-dose bisphenol A increases prostate size in rats by affecting certain enzymes.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Caesalpinia bonduc seed extracts may help treat enlarged prostate in rats.

Finasteride before TURP reduces blood loss and slightly improves early postoperative quality of life.

Saw palmetto extract is generally safe and can effectively treat Lower Urinary Tract Symptoms, but its evaluation is affected by varying quality and a need for long-term studies.

Male pattern baldness does not cause an increased risk of prostate cancer.

CT scans can find serious prostate cancer even when PSA levels are low.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Many men with male pattern baldness have abnormal blood fat levels, which may raise their risk of heart disease.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Using finasteride with TIP extends time off period for prostate cancer patients.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.